BioLargo's Innovations in Cleantech Begin to Yield Results
July 23rd, 2025 4:53 PM
By: Newsworthy Staff
BioLargo Inc. is seeing the fruits of its long-term R&D efforts in cleantech and life sciences, with its innovations in odor control, PFAS remediation, battery storage, and medical devices starting to gain market traction.

BioLargo Inc., a cleantech and life sciences company, is beginning to reap the benefits of its extensive research and development in solving environmental challenges. The company's president and CEO, Dennis Calvert, highlighted the progress in an interview with Benzinga, noting the long development cycles and significant competition in the field. BioLargo's focus areas include odor and VOC controls, PFAS groundwater remediation and treatment, battery storage technology, and medical devices.
Calvert expressed particular excitement about the company's battery storage unit, Cellinity, which has recently received third-party validation. This technology is crucial for grid-scale battery energy storage applications, a market that is currently expanding rapidly due to the inefficiency of existing energy supplies to meet the growing demands, especially in support of AI expansion. The success of Cellinity and other BioLargo innovations underscores the company's transition from development to commercialization, marking a significant milestone in its growth trajectory.
For more details on the interview, visit https://www.youtube.com/watch?v=OlH4H2MrgLI.
Source Statement
This news article relied primarily on a press release disributed by NewMediaWire. You can read the source press release here,
